Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP383821.RArgXYHuxf4-AZm7mQPR5tvddnureBYShCk0YsvMw2lqk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP383821.RArgXYHuxf4-AZm7mQPR5tvddnureBYShCk0YsvMw2lqk130_assertion type Assertion NP383821.RArgXYHuxf4-AZm7mQPR5tvddnureBYShCk0YsvMw2lqk130_head.
- NP383821.RArgXYHuxf4-AZm7mQPR5tvddnureBYShCk0YsvMw2lqk130_assertion description "[The reduction of ADARB2 correlated with the grade of malignancy of glioblastoma multiforme, the most aggressive of brain tumors, displaying a 99% decrease in ADARB2 RNA levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383821.RArgXYHuxf4-AZm7mQPR5tvddnureBYShCk0YsvMw2lqk130_provenance.
- NP383821.RArgXYHuxf4-AZm7mQPR5tvddnureBYShCk0YsvMw2lqk130_assertion evidence source_evidence_literature NP383821.RArgXYHuxf4-AZm7mQPR5tvddnureBYShCk0YsvMw2lqk130_provenance.
- NP383821.RArgXYHuxf4-AZm7mQPR5tvddnureBYShCk0YsvMw2lqk130_assertion SIO_000772 17908822 NP383821.RArgXYHuxf4-AZm7mQPR5tvddnureBYShCk0YsvMw2lqk130_provenance.
- NP383821.RArgXYHuxf4-AZm7mQPR5tvddnureBYShCk0YsvMw2lqk130_assertion wasDerivedFrom befree-20140225 NP383821.RArgXYHuxf4-AZm7mQPR5tvddnureBYShCk0YsvMw2lqk130_provenance.
- NP383821.RArgXYHuxf4-AZm7mQPR5tvddnureBYShCk0YsvMw2lqk130_assertion wasGeneratedBy ECO_0000203 NP383821.RArgXYHuxf4-AZm7mQPR5tvddnureBYShCk0YsvMw2lqk130_provenance.